Exhibit 10.1

 

TERMINATION AGREEMENT

 

This Termination Agreement (this “Agreement”) is entered into as of March 14,
2016 by and among Emmaus Life Sciences, Inc. (the “Company”), Yutaka Niihara
(“Niihara”), and T.R. Winston & Company, LLC (“TRW”) in respect of that certain
Agreement that was entered into as of September 11, 2013 by the Company,
Niihara, Sarissa Capital Management L.P. (“Sarissa”) and TRW and that was
amended by the Company, Niihara and Sarissa on November 19, 2015 (as so amended,
the “Designation Agreement”).

 

1.                                    Definitions.  Terms not otherwise defined
in this Agreement shall have the meanings attributed to such terms in the
Designation Agreement.

 

2.                                    Termination of Designation Agreement;
Waivers.

 

(a)                               The Designation Agreement is hereby terminated
and the Company, Niihara and TRW shall have no further rights or obligations to
each other under the Designation Agreement.

 

(b)                              As a material inducement to each of the other
parties to enter into this Agreement, and without limitation of the other terms
set forth herein, each of the Emmaus Parties, on the one hand, and TRW, on the
other hand, hereby irrevocably and unconditionally (i) waives fully and forever
any and all rights (whether known or unknown) each has ever had, has or may have
under the Designation Agreement against each other, and (ii) waives and releases
each other fully and forever from any and all obligations each has ever had, has
or may have to the other under the Designation Agreement.

 

3.                                    D&O Insurance.  The Company (a) represents
and warrants to TRW that it currently maintains directors’ and officers’ (“D&O”)
liability insurance that provides coverage, on the terms and conditions set
forth in the policy contract, for past directors of the Company, and (b) agrees
to use commercially reasonable best efforts to maintain D&O liability insurance
that provides coverage for past directors on substantially similar terms and
conditions as are set forth in the Company’s current policy.

 

4.                                    No Effect on Subscription Agreements.  It
is acknowledged and agreed that this Agreement has no effect on the subscription
agreements entered into on or around September 11, 2013 by and between the
Company, on the one hand, and various investors (the “Investors”) whose purchase
of Company securities was arranged by TRW in its capacity as the Company’s
placement agent (the “Subscription Agreements”).  The Subscription Agreements,
including without limitation the rights set forth therein with respect to the
Investors’ resale of Company securities, shall remain in effect on the terms and
conditions set forth therein.

 

5.                                    General Representations, Warranties and
Agreements.

 

(a)                               Each party warrants and represents to each of
the other parties that such party has not heretofore assigned, subrogated or
transferred to any natural person, firm, partnership, corporation or entity
whatsoever any claim, right or interest under the Designation Agreement.  In the
event that any claim, demand, cause of action or suit is made or initiated
against a party to this Agreement because of any such purported prior
assignment, transfer or subrogation of any such claim, right or interest, the
assigning, transferring or subrogating party shall indemnify, defend and hold
harmless the other parties from any such claim, demand, cause of action or suit,
and from any such purported assignment, subrogation or transfer.

 

 

--------------------------------------------------------------------------------

 

(b)                              Each party warrants and represents to each of
the other parties that such party is entering into this Agreement without duress
or undue influence, in good faith and for sufficient consideration, and that
this Agreement is fair, just and reasonable as to such party.  Each party enters
into this Agreement with full knowledge of any and all rights that such party
may have by reason of or in relation to the Designation Agreement.

 

(c)                               Each party warrants and represents to each of
the other parties that this Agreement has been duly and validly authorized by
all requisite corporate or other company action of such party, if applicable,
has been duly and validly executed and delivered by such party, and constitutes
the valid and binding obligation of such party, enforceable against such party
in accordance with its terms.

 

6.                                    No Other Terms.  In entering into this
Agreement, it is understood and agreed that the parties are relying wholly upon
their own judgment, belief and knowledge, and except to the extent expressly
stated herein, that they have not been influenced to any extent whatsoever in
making this Agreement by any representations or statements regarding said
damages or regarding any other matter made by the persons, firms, entities or
corporations who are hereby released, or by any person representing the parties.

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
date first set forth above.

 

 

 

/s/Yutaka Niihara

 

 

Yutaka Niihara, M.D., M.P.H.

 

 

 

EMMAUS LIFE SCIENCES, INC.

 

 

 

 

By:

/s/Yutaka Niihara

 

 

 

Name:

Yutaka Niihara, M.D., M.P.H.

 

 

Title:

Chief Executive Officer

 

 

 

 

 

T.R. WINSTON & COMPANY, LLC

 

 

 

By:

/s/G Tyler Runnels

 

 

 

Name:

G. Tyler Runnels

 

 

Title:

CEO

 

 

2

--------------------------------------------------------------------------------